SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to a major regulatory pivot after the FDA signaled a willingness to review an amendment to its BLA, which includes 24-month HOPE-3 study data focused on upper-limb function. The community is actively debating the potential for a short squeeze amid high short interest and institutional buying, while conflicting perspectives persist regarding whether this amendment offers a genuine path to approval or simply delays an inevitable rejection.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is trending as investors react to strong quarterly earnings, including triple-digit revenue growth and raised financial guidance, which have sparked a surge in institutional buying and community enthusiasm. The stock is currently a focal point for traders tracking upcoming government quantum sensor contract awards and the potential for a short squeeze given the significant interest from both institutional investors and those anticipating a major technical re-rating.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlist is trending as investors react to a landmark patent settlement with Samsung, which provides a massive infusion of cash and supply stability while signaling potential breakthroughs in ongoing litigation against Micron and Google. The community is actively discussing the potential for a significant short squeeze and long-term valuation re-rating as the company gains leverage in the AI-driven memory infrastructure sector.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is trending as institutional investors rally behind the stock following a successful investor day, with bullish sentiment fueled by strong long-term AI-driven revenue contracts and aggressive share buyback plans. While retail traders debate the sustainability of the recent surge versus potential cooling in the memory cycle, the stock continues to see significant momentum driven by institutional capital and strategic partnerships.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is currently seeing heightened community interest as market participants track institutional buying through spot ETFs while analyzing the impact of potential regulatory developments and shifting macro sentiment. Investors are actively debating the asset's technical consolidation near key levels as they weigh the long-term potential for infrastructure-driven growth against ongoing volatility in the broader crypto space.

Aventus Network

Aventus Network is experiencing extreme volatility and intense community speculation following a sharp price decline and reports of exchange connectivity issues. Investors are actively debating whether the current low price presents a unique entry opportunity for a long-term infrastructure play or if the asset faces ongoing manipulation and liquidity risks.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is surging toward all-time highs as a massive short squeeze intensifies, fueled by high-profile contrarian bets that have drawn heavy criticism and mockery from the community. Investors remain intensely focused on the company's aggressive expansion in AI infrastructure and potential technical catalysts that are forcing short sellers to cover their positions.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance is experiencing significant upward momentum driven by record revenue and margin expansion reported in Q2, as the community eagerly anticipates updated full-year guidance and upcoming clinical catalysts like the LUN-202 lung cancer readout. Investors are actively discussing the potential for a short squeeze given the substantial short interest, while many remain focused on the company's long-term transformation into a multi-indication platform.

ETF Opportunities Trust - T-REX 2X Long SNDK Daily Target ETF

The T-REX 2X Long SNDK Daily Target ETF (SNDU) is experiencing significant momentum and volatility, driven largely by investors utilizing the fund to capitalize on the rapid upward price movement and high-profile buybacks of its underlying asset, SanDisk. Community discourse is heavily focused on technical trading strategies, such as swing trading leveraged positions and monitoring order flow ahead of anticipated company-specific news events, with many participants viewing the current environment as a high-reward opportunity despite the inherent risks of leveraged products.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company’s FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company’s ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is trending as investors react to a significant growth outlook driven by the ongoing commercial scaling of its flagship drug VEVYE and new retinal portfolio assets. The community is actively debating the company's ability to align operational execution with its ambitious revenue goals, while also weighing the potential impact of pending regulatory milestones and recent insider activity on future performance.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here you have the $COMPQ VERSUS the 10 day ma of adv-decl in NYSE, NASDAQ, AMEX

A Joe

Stocktwits

NASDAQ Composite Index

 VERSUS the 10 day ma of adv-decl in NYSE, NASDAQ, AMEX